Hebei Changshan Biochemical Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, marketing, and sale of d...
Changshan Pharmaceutical Shares Trigger Abnormal Trading Alert After Three-Day Drop
The three major A-share indices collectively fell at the midday break, with CSBIO dropping over 17%
The innovative drug concept fluctuates and declines, CSBIO falls over 15%
CSBIO's stock price hits a new high
CSBIO released its performance for the first three quarters, with a net loss attributable to shareholders of 44.8174 million yuan
A-share innovative drug concept stocks fluctuated and rose, Wolwo Pharma increased by over 10%, Chemexpress rose by over 9%, Fushine, CSBIO, and Medicilon followed suit